CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Income Statement
CELZ|14 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 14 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$6,000
FY2025
Gross Profit
$3,806
63.4% gross margin
Operating Income
-$6M
FY2025
Net Income
-$6M
FY2025
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. reported $6,000 in revenue and $6M in net loss for FY2025. Revenue has grown at a 3.2% compound annual rate over the past 7 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0K | $11.0K | $88.6K | $87.8K | $164.5K | $165.5K | $124.4K | $4.8K | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $2.2K | $4.4K | $28.5K | $47.9K | $50.6K | $45.5K | $70.4K | $8.0K | $0 | - | - | - | - | - |
| Gross Profit | $3.8K | $6.6K | $60.1K | $39.8K | $113.9K | $120.0K | $54.0K | -$3.2K | $0 | - | - | - | - | - |
| SG&A Expense | $3.8M | $3.2M | $3.9M | $3.0M | $1.2M | $1.2M | $1.1M | $898.5K | $665.0K | $665.0K | - | - | - | - |
| R&D Expense | $2.3M | $2.4M | $6.3M | $109.2K | $0 | $0 | $96.6K | $260.1K | $85.3K | $85.3K | - | - | - | - |
| Operating Income | -$6.1M | -$5.7M | -$10.2M | -$3.1M | -$1.1M | -$1.1M | -$1.1M | -$1.2M | -$759.7K | -$766.1K | -$19.4K | -$20.1K | -$20.1K | -$14.3K |
| Interest Expense | - | - | - | $4.3M | $1.2M | $1.9M | $1.4M | $377.6K | $6.4K | - | - | - | - | - |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | - | - | - | - |
| Net Income | -$6.0M | -$5.5M | -$10.1M | $19.2M | -$36.3M | -$8.5M | -$13.7M | -$2.7M | -$766.1K | -$766.1K | -$28.0K | -$27.3K | -$25.6K | -$17.3K |
| EPS (Basic) | - | - | - | $7.37 | -$62.69 | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$3.71 | -$3.76 | - | $5.61 | -$62.69 | -$0.82 | -$3.50 | -$0.03 | -$0.01 | -$0.01 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding | 1.7M | 1.4M | 1.4M | 6.3M | 1.5M | 22.5M | 6.0M | 114.8M | 105.0M | 32.0M | 18.1M | 18.1M | 18.1M | 18.1M |
| Gross Margin | 63.4% | 60.0% | 67.8% | 45.4% | 69.2% | 72.5% | 43.4% | -66.7% | - | - | - | - | - | - |
| Operating Margin | -102380.2% | -52216.9% | -11562.5% | -3562.2% | -677.7% | -682.9% | -895.7% | -24537.6% | - | - | - | - | - | - |
| Profit Margin | -99916.8% | -49940.7% | -11449.3% | 21892.8% | -22082.2% | -5126.1% | -10977.2% | -55398.1% | - | - | - | - | - | - |